Herceptin - Globe Thesis

Keyword [Herceptin] Result: 41 - 60 \| Page: 3 of 4
41.	The Study Of The Cellular Immune Therapy Of Her-2Pulsed DCIKs Against Intractable Breast Cancer Cells
42.	The Effects Of Erbin On The Migration Capacity And Herceptin Resistance Of Her2Positive Breast Cancer Cells And Its Relative Mechanism
43.	The Significance Of HER2/neu And The Effect Of Targeted Drug On The Esophageal Squamous Carcinoma
44.	Anti-Her2 Antibody Stability Modification And Function Optimization
45.	Paclitaxel-Loaded Targeted Magnetic Nanoprobe For Dual-Mode Imaging And Therapy Of Breast Cancer
46.	Up-regulation Of Muc4by β2-AR Activation Induces The Resistance To Herceptin Of Grastric Cancer Cells
47.	The Effect And Mechanisms Of ER Non-genomic Activity On Up-regulation Of FEN1and Herceptin Resistance In Breast Cancer Cells
48.	Studies On The Antitumor Effects Of Protein Glycosylation Inhibitor Tunicamycin Alone And In Combination With HER2-target Drug Herceptin
49.	The Effects Of Herceptin In Combination With Rapamycin On Proliferation And Apoptosis In Human Gastric Cancer Cells NCI-N87
50.	CNCCN Significance For The Treatmeng Of Her-2Overexpressing Breast Cancer
51.	Research On Regulating Mechanisms Of Herceptin On The Amplification And Cytotoxicity Of Natural Killer Cells In Vitro
52.	The Chemotherapy Sensitizing Effect Of131I-herceptin On Ovarian Cancer Cell SKOV-3
53.	HER2 Expression In The EOC And In Vitro Effects Of Herceptin To The Ovarian Cancer Cells SKOV3
54.	Preparation Of Gold Nanorods-porphyrin And Its Application In Tumor Thermal Technology
55.	The Novel Effects And Mechanisms Of Estrogen Receptor α 36 In Resistance To Breast Cancer Drugs
56.	Preparation Of Herceptin-gold Nanoprobe And Its Inhibitory Effect On Breast Cancer Cells
57.	Research On Inhibition On Herceptin-resistant And Functional Optimization Of Anti-HER3 Antibody
58.	Dihydromyricetin Enhanced Sensitivity Effect On The Drug-Resistant Human Breast Cancer SKBR3 Cells Induced By Herceptin Through Inhibiting PI3K/AKT Signal Activation In Vitro And In Vivo
59.	Acute Cardiotoxicity In The Setting Of Concurrent Trastuzumab And Posto Perative Adjuvant Therapy Of Breast Cancer
60.	MiR-6X Axis Regulates Herceptin Resistance In Breast Cancer
<<First <Prev Next> Last>> Jump to